Effects of Ulipristal Acetate on Reactive Oxygen Species and Proinflammatory Cytokine Release by Epithelial and Stromal Cells from Human Endometrium and Endometriosis.
CCL2
Endometriosis
Endometrium
IL-6
Oxidative stress
Reactive oxygen species
Ulipristal acetate
Journal
Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249
Informations de publication
Date de publication:
12 Sep 2023
12 Sep 2023
Historique:
received:
10
02
2023
accepted:
28
08
2023
medline:
13
9
2023
pubmed:
13
9
2023
entrez:
12
9
2023
Statut:
aheadofprint
Résumé
Endometriosis is a condition characterized by increased oxidative stress and chronic inflammation, which can be treated with progestins and other progesterone receptor ligands. However, some patients are refractory to this treatment and the reason is uncertain. Here we investigated the effects of the selective progesterone receptor modulator ulipristal acetate (UPA) on proliferation, reactive oxygen species (ROS), and proinflammatory cytokine production by endometriotic cells and endometrial cells from women with histologically proven endometriosis (n = 22) and endometriosis-free controls (n = 6). Epithelial and stromal cells were isolated and treated in triplicate for 24 h with 1 μM, 10 μM, or 100 μM UPA. Cells were tested for proliferation and ROS production, while cell supernatants were assayed for interleukin (IL)-6, C-C motif chemokine ligand 2 (CCL2), and tumor necrosis factor (TNF)-α concentrations. Proliferation, ROS production, and IL-6 and CCL2 secretion were increased in non-stimulated epithelial and stromal cells from endometriotic lesions compared to endometrial cells from endometriosis patients and controls. UPA induced a dose-dependent increase of cell proliferation only in endometriosis, while enhancing ROS production by all cell types evaluated. UPA reduced CCL2 production in controls but failed to do that in endometriosis, whereas TNF-α was undetectable. We conclude that treatment of endometriotic cells with UPA stimulated in vitro proliferation and ROS production and failed to revert the proinflammatory cytokine excess that characterized these cells, unravelling possible mechanisms of drug resistance in the treatment of endometriosis.
Identifiants
pubmed: 37700209
doi: 10.1007/s43032-023-01341-6
pii: 10.1007/s43032-023-01341-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 201876/2017-5
Informations de copyright
© 2023. The Author(s), under exclusive licence to Society for Reproductive Investigation.
Références
Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397:839–52.
doi: 10.1016/S0140-6736(21)00389-5
pubmed: 33640070
Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15:666–82.
doi: 10.1038/s41574-019-0245-z
pubmed: 31488888
Reis FM, Coutinho LM, Vannuccini S, Batteux F, Chapron C, Petraglia F. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure. Hum Reprod Update. 2020;26:565–85.
doi: 10.1093/humupd/dmaa009
pubmed: 32412587
pmcid: 7317284
Reis FM, Petraglia F, Taylor RN. Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update. 2013;19:406–18.
doi: 10.1093/humupd/dmt010
pubmed: 23539633
pmcid: 3682670
Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril. 2016;106:1552-71.e2.
doi: 10.1016/j.fertnstert.2016.10.022
pubmed: 27817837
Fazleabas AT. Progesterone resistance in a baboon model of endometriosis. Semin Reprod Med. 2010;28:75–80.
doi: 10.1055/s-0029-1242997
pubmed: 20104431
Singh SS, Evans D, McDonald S, Senterman M, Strickland S. Ulipristal acetate prior to surgery for endometriosis. Reprod Sci. 2020;27:1707–14.
doi: 10.1007/s43032-020-00146-1
pubmed: 32006245
Whitaker LH, Murray AA, Matthews R, Shaw G, Williams AR, Saunders PT, et al. Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium. Hum Reprod. 2017;32:531–43.
pubmed: 28130434
pmcid: 5400066
Salas A, Vázquez P, Bello AR, Báez D, Almeida TA. Dual agonist-antagonist effect of ulipristal acetate in human endometrium and myometrium. Expert Rev Mol Diagn. 2021;21:851–7.
doi: 10.1080/14737159.2021.1941878
pubmed: 34110938
Kannan A, Bhurke A, Sitruk-Ware R, Lalitkumar PG, Gemzell-Danielsson K, Williams ARW, et al. Characterization of molecular changes in endometrium associated with chronic use of progesterone receptor modulators: ulipristal acetate versus mifepristone. Reprod Sci. 2018;25:320–8.
doi: 10.1177/1933719117746764
pubmed: 29241443
González-Foruria I, Santulli P, Chouzenoux S, Carmona F, Chapron C, Batteux F. Dysregulation of the ADAM17/Notch signalling pathways in endometriosis: from oxidative stress to fibrosis. Mol Hum Reprod. 2017;23:488–99.
doi: 10.1093/molehr/gax028
pubmed: 28486700
Ngô C, Chéreau C, Nicco C, Weill B, Chapron C, Batteux F. Reactive oxygen species controls endometriosis progression. Am J Pathol. 2009;175:225–34.
doi: 10.2353/ajpath.2009.080804
pubmed: 19498006
pmcid: 2708809
Santulli P, Chouzenoux S, Fiorese M, Marcellin L, Lemarechal H, Millischer AE, et al. Protein oxidative stress markers in peritoneal fluids of women with deep infiltrating endometriosis are increased. Hum Reprod. 2015;30:49–60.
doi: 10.1093/humrep/deu290
pubmed: 25376454
Su RW, Strug MR, Jeong JW, Miele L, Fazleabas AT. Aberrant activation of canonical Notch1 signaling in the mouse uterus decreases progesterone receptor by hypermethylation and leads to infertility. Proc Natl Acad Sci U S A. 2016;113:2300–5.
doi: 10.1073/pnas.1520441113
pubmed: 26858409
pmcid: 4776514
Bateman J, Bougie O, Singh S, Islam S. Histomorphological changes in endometriosis in a patient treated with ulipristal: a case report. Pathol Res Pract. 2017;213:79–81.
doi: 10.1016/j.prp.2016.10.010
pubmed: 27914766
Chapron C, Lafay-Pillet MC, Monceau E, Borghese B, Ngo C, Souza C, et al. Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis. Fertil Steril. 2011;95:877–81.
doi: 10.1016/j.fertnstert.2010.10.027
pubmed: 21071024
Maignien C, Santulli P, Chouzenoux S, Gonzalez-Foruria I, Marcellin L, Doridot L, et al. Reduced α-2,6 sialylation regulates cell migration in endometriosis. Hum Reprod. 2019;34:479–90.
doi: 10.1093/humrep/dey391
pubmed: 30753458
Peyneau M, Kavian N, Chouzenoux S, Nicco C, Jeljeli M, Toullec L, et al. Role of thyroid dysimmunity and thyroid hormones in endometriosis. Proc Natl Acad Sci U S A. 2019;116:11894–9.
doi: 10.1073/pnas.1820469116
pubmed: 31142643
pmcid: 6575600
Nandakumar R, Praditpan P, Westhoff CL, Cremers S. A UPLC-MS/MS method for the quantitation of ulipristal acetate in human serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1059:43–8.
doi: 10.1016/j.jchromb.2017.05.024
pubmed: 28570936
Bressler LH, Bernardi LA, Snyder MA, Wei JJ, Bulun S. Treatment of endometriosis-related chronic pelvic pain with ulipristal acetate and associated endometrial changes. HSOA J Reprod Med Gynaecol Obstet. 2017;2:008.
Grandi G, Mueller M, Bersinger N, Papadia A, Nirgianakis K, Cagnacci A, et al. Progestin suppressed inflammation and cell viability of tumor necrosis factor-alpha-stimulated endometriotic stromal cells. Am J Reprod Immunol. 2016;76:292–8.
doi: 10.1111/aji.12552
pubmed: 27515307
Gou Y, Li X, Li P, Zhang H, Xu T, Wang H, et al. Estrogen receptor beta upregulates CCL2 via NF-kappaB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis. Hum Reprod. 2019;34:646–58.
doi: 10.1093/humrep/dez019
pubmed: 30838396
Coutinho LM, Vieira EL, Dela Cruz C, Casalechi M, Teixeira AL, Del Puerto HL, et al. Apoptosis modulation by activin A and follistatin in human endometrial stromal cells. Gynecol Endocrinol. 2016;32:161–5.
doi: 10.3109/09513590.2015.1103222
pubmed: 26494397
Nasu K, Narahara H, Matsui N, Kawano Y, Tanaka Y, Miyakawa I. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. Mol Hum Reprod. 1999;5:548–53.
doi: 10.1093/molehr/5.6.548
pubmed: 10341002
Machin D, Campbell MJ, Fayers PM, Pinol APY. Sample size tables for clinical studies. 2nd ed. Blackwell Science; 1997.
Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382:1244–56.
doi: 10.1056/NEJMra1810764
pubmed: 32212520
Mangioni S, Vigano P, Florio P, Borghi O, Vignali M, Petraglia F, et al. Effect of activin A on tumor necrosis factor-alpha/intercellular adhesion molecule-1 pathway in endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol. 2005;123:218–23.
doi: 10.1016/j.ejogrb.2005.03.017
pubmed: 15893868
Wei X, Liu Y, Li W, Shao X. Nucleotide-binding oligomerization domain-containing protein 1 regulates inflammatory response in endometriosis. Curr Protein Pept Sci. 2022;23:121–8.
doi: 10.2174/1389203723666220322125031
pubmed: 35319362
Chodankar RR, Murray A, Nicol M, Whitaker LHR, Williams ARW, Critchley HOD. The endometrial response to modulation of ligand-progesterone receptor pathways is reversible. Fertil Steril. 2021;116:882–95.
doi: 10.1016/j.fertnstert.2021.02.008
pubmed: 33865567
Kolanska K, Sbeih M, Canlorbe G, Mekinian A, Varinot J, Capmas P et al. Ulipristal acetate modifies miRNA expression in both superficial and basal layers of the human endometrium. J Clin Med. 2021;10:4442.
Lete I, Mendoza N, de la Viuda E, Carmona F. Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain in the treatment of endometriosis-associated pelvic pain: LEAP study. Eur J Obstet Gynecol Reprod Biol. 2018;228:221–4.
doi: 10.1016/j.ejogrb.2018.07.002
pubmed: 30007250
Amini L, Chekini R, Nateghi MR, Haghani H, Jamialahmadi T, Sathyapalan T, et al. The effect of combined vitamin C and vitamin e supplementation on oxidative stress markers in women with endometriosis: a randomized, triple-blind placebo-controlled clinical trial. Pain Res Manag. 2021;2021:5529741.
doi: 10.1155/2021/5529741
pubmed: 34122682
pmcid: 8172324
Khodarahmian M, Amidi F, Moini A, Kashani L, Salahi E, Danaii-Mehrabad S, et al. A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women. J Reprod Immunol. 2021;143:103248.
doi: 10.1016/j.jri.2020.103248
pubmed: 33387724